Valuation: Amoéba

Market Cap 47.81M 55.18M 44.79M 40.86M 76.81M 5.26B 77.99M 527M 206M 2.64B 207M 203M 8.79B P/E 2026 *
-9.25x
P/E 2027 * 69.4x
Enterprise Value 58.96M 68.05M 55.24M 50.38M 94.72M 6.49B 96.18M 650M 254M 3.25B 255M 250M 10.84B EV / Sales 2026 *
11.6x
EV / Sales 2027 * 3.84x
Free-Float
87.09%
Yield 2026 *
-
Yield 2027 * -
1 week-3.96%
Current month-3.16%
1 month-6.75%
3 months-21.69%
6 months-20.00%
Current year-25.89%
1 week 0.66
Extreme 0.662
0.74
1 month 0.62
Extreme 0.616
0.76
3 years 0.34
Extreme 0.3415
1.34
5 years 0.34
Extreme 0.3415
1.75
Manager TitleAgeSince
Chief Executive Officer 60 13/12/2023
Chief Tech/Sci/R&D Officer - 31/08/2018
Corporate Officer/Principal - 28/02/2022
Director TitleAgeSince
Director/Board Member - 31/05/2014
Chairman 70 13/12/2023
Director/Board Member 70 24/05/2023
Change 5-day change 1-year change 3-year change Capi.($)
-3.84%-3.96%-14.15%+17.73% 55.18M
-0.13%-2.42%-16.88%-24.41% 3.22B
+0.37%+0.64%+8.33%-1.80% 2.19B
+1.11%+2.05%-20.61%-34.18% 1.82B
-0.28%-2.94%+17.76%+2.90% 1.68B
+2.41%+3.73%-22.15% - 1.56B
-0.59%-2.40%-16.23%-47.17% 1.37B
+0.22%-0.76%-26.12%+35.97% 1.34B
-1.30%-3.77%-9.35%-18.10% 1.26B
-0.69%+4.16%-29.63%+80.05% 1.1B
Average +0.12%-1.02%-12.90%+1.22% 1.73B
Weighted average by Cap. +0.18%-0.90%-11.59%-6.40%

Financials

2026 *2027 *
Net sales 5.1M 5.89M 4.78M 4.36M 8.19M 561M 8.32M 56.2M 21.97M 281M 22.1M 21.62M 937M 15.55M 17.95M 14.57M 13.29M 24.98M 1.71B 25.37M 171M 66.98M 857M 67.39M 65.92M 2.86B
Net income -5.2M -6M -4.87M -4.44M -8.35M -572M -8.48M -57.3M -22.4M -287M -22.53M -22.04M -956M 550K 635K 515K 470K 884K 60.55M 897K 6.06M 2.37M 30.32M 2.38M 2.33M 101M
Net Debt 11.15M 12.87M 10.45M 9.53M 17.91M 1.23B 18.19M 123M 48.03M 615M 48.32M 47.27M 2.05B 11.85M 13.68M 11.1M 10.13M 19.04M 1.3B 19.33M 131M 51.04M 653M 51.35M 50.24M 2.18B
Logo Amoéba
Amoéba is a greentech company whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. With know-how that is unique in the world and protected by numerous patents, Amoéba is currently the only company capable of exploiting the full potential of the Willaertia amoeba on an industrial scale and cultivating it in sufficient volumes to offer biological solutions that constitute a viable alternative to the chemical products widely used today. Amoéba is currently focusing on the global biocontrol market for plant protection and on the cosmetics market.
Employees
-
Date Price Change
13/08/26 0.6770 -3.84%
12/08/26 €0.7040 +2.03%
11/08/26 €0.6900 -0.29%
10/08/26 €0.6920 -6.74%
07/08/26 €0.7420 +2.63%
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.6940EUR
Average target price
1.400EUR
Spread / Average Target
+101.73%

Annual profits - Rate of surprise